Lexogen, a Vienna-based biotech company specialized in RNA transcriptomics technologies and services announces the completion ...
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, representing more than 30% of all pediatric cases. A pilot study in The Journal of Molecular Diagnostics, published by Elsevier, ...
This study presents a valuable tool named TSvelo, a computational framework for RNA velocity inference that models transcriptional regulation and gene-specific splicing. The evidence supporting the ...
Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab The prognostic model demonstrated ...
RNA sequencing has emerged as a powerful supplement to DNA sequencing for Mendelian disease diagnosis, but clinical translation of diagnostic RNA-seq has not been widely achieved. Researchers at ...
Breast cancer is a highly heterogeneous malignancy among women worldwide. Traditional prognostic models relying solely on ...
Researchers at the University of Toronto's Temerty Faculty of Medicine have found widespread genetic and protein changes in ...
SPT Labtech, Pacific Biosciences to automate Kinnex full-length RNA-seq library preparation on SPT’s firefly liquid handling platform: Cambridge, UK Monday, November 24, 2025, 1 ...
Eight years ago, 10x Genomics launched the first commercially available single-cell RNA sequencing (scRNA-seq) product for the company’s flagship instrument, the 10x Chromium. (This occurred one year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results